AR and neoplasm: Indeed, activation of both the progesterone receptor (PR) and the androgen receptor (AR) have been shown to reprogram the ER cistrome: reinstalling a gene-expression program of favorable outcome (Mohammed et al, 2015) and repressing ER-regulated cell cycle genes, whilst upregulating known tumor suppressors (Hickey et al, 2021).